This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Spectrum Pharmaceuticals Class Action Lawsuit
Business class action

Spectrum Pharmaceuticals Class Action Lawsuit

Analysis based on 7 articles · First reported Aug 24, 2025 · Last updated Sep 19, 2025

Sentiment
-20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is impacted by the potential financial liability for Spectrum Pharmaceuticals due to the class action lawsuit, which could negatively affect its stock price. Investors who purchased Spectrum Pharmaceuticals common stock during the Class Period may be entitled to compensation.

Pharmaceuticals Legal Services
Event Summary

Rosen Law Firm has filed a class action lawsuit against Spectrum Pharmaceuticals, alleging that the company made false or misleading statements to investors regarding its PINNACLE Study, a clinical trial for the drug poziotinib, intended to treat lung cancer patients. The lawsuit claims that investors suffered damages when the true details about the study entered the market. The lead plaintiff deadline for investors to join the class action is September 24, 2025. Rosen Law Firm, through attorneys Philip Kim and Lawrence Rosen, is encouraging affected investors to secure counsel.

Entities Involved
stock
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals is the defendant in a class action lawsuit alleging false or misleading statements regarding its PINNACLE Study and poziotinib drug, which could lead to financial damages.
Importance 100.0 Sentiment -50.0
priv
Rosen Law Firm
Rosen Law Firm is representing investors in a class action lawsuit against Spectrum Pharmaceuticals, seeking compensation for alleged damages.
Importance 80.0 Sentiment 20.0
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a contact person for investors interested in joining the class action lawsuit against Spectrum Pharmaceuticals.
Importance 30.0 Sentiment 10.0
per
Lawrence Rosen
Lawrence Rosen, a founding partner of Rosen Law Firm, is mentioned for his firm's track record in securities class actions.
Importance 30.0 Sentiment 10.0
Relationships
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.